TCL Archive FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials July 27, 2012Vol.38 No.30
TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012Vol.35 No.7
TCL Archive Conversation with The Cancer Letter: Statistician Lori Dodd Saw Research Question In the Midst of 2007 ODAC Debate Over Avastin July 27, 2012Vol.38 No.30
TCL Archive FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer July 27, 2012Vol.35 No.7
TCL Archive Phase III Study Evaluating Halaven Fails To Meet Primary Endpoints July 27, 2012Vol.35 No.7
TCL Archive Upper Endoscopy Most Effective When Performed in 3-Year Intervals July 27, 2012Vol.35 No.7
TCL Archive Women Who Concieve Using Fertility Drugs Have a Higher Risk Of Breast Cancer Than Non-Users July 27, 2012Vol.35 No.7
